Search:
Advanced Search
Explore: 
Contact: webinfo@valleyhealth.com Phone Numbers >
LinkedIn Instagram Soundcloud
Book Online

with select Valley
Medical Group doctors

zoc-doc logo

Choose Another
Program or Service
223 N. Van Dien Avenue Ridgewood, NJ 07450
201-447-8000
Mailing Address:
The Valley Hospital
223 N. Van Dien Avenue
Ridgewood, NJ 07450

Fusion Guided Biopsy: Diagnosing Prostate Cancer with Pinpoint Accuracy

 
  

September 13, 2017—There is a new technology available that can help with both predicting prostate cancer aggressiveness and detecting prostate cancer. It’s called fusion guided biopsy, and Valley–Mount Sinai Comprehensive Cancer Care is proud to offer the UroNav Fusion Biopsy System to its patients as an outpatient procedure.

“This targeted MRI/ultrasound biopsy is poised to become a new standard in prostate cancer screening,” explains Howard Frey, M.D., Medical Director, The Urologic Oncology Center, Valley-Mount Sinai Comprehensive Cancer Care. “The advanced technology will help us to more accurately diagnosis prostate cancer, which is the most common cancer among men after skin cancer.”

The UroNav Fusion Biopsy System fuses pre-biopsy MRI images of the prostate with ultrasound-guided biopsy images in real time to target suspicious areas for biopsy. This allows for a much more effective and precise prostate biopsy than the standard biopsy. “Prostate cancer can be hard to detect, because patients often do not have symptoms at the time of diagnosis. Deciding what to do about prostate cancer can be challenging, continues Dr. Frey. “It is important to distinguish between aggressive, potentially lethal prostate tumors, and those that are indolent and not life-threatening.”

In a standard biopsy, the tissue sampling is done via ultrasound, but there are no targeted areas.  This can pose an issue if the prostate is enlarged because random sampling without a target can miss an aggressive tumor, but find inconsequential non-aggressive prostate cancer that does not require treatment.  

Fusion Biopsy greatly improves on the standard technique. First, a prostate MRI is obtained.  If a suspicious area is identified, the result is fused with the live prostate ultrasound providing a target to biopsy.  Thus a directed biopsy is obtained and is more likely to show an intermediate to aggressive cancer.  The biopsy results are then utilized to guide patients in selecting an appropriate treatment modality.

About Valley-Mount Sinai Comprehensive Cancer Care’s Urologic Oncology Center

Valley-Mount Sinai Comprehensive Cancer Care offers a multidisciplinary Urologic Oncology Center, a unique program that serves as a one-stop, complete resource for patients who have prostate and other urologic cancers. Patients at The Valley Hospital's Urologic Oncology Center are treated by a multidisciplinary team that closely reviews each case and comes to a consensus about a suggested treatment regimen. The team consists of urology, radiation oncology, medical oncology and a urology nurse navigator.  They provide a high level of care that incorporates evidence-based medicine and the newest protocols in the field. Patients are able to see all of the necessary medical disciplines within a two hour appointment, facilitating their treatment decision. 

For more information on The Valley Hospital's Urologic Oncology Center, please call 201-634-5567.

All News & Events
 
"To Your Health" Blog
Ovarian Cancer: Risk Factors, Symptoms, Diagnosis and Treatment 09-08-17

Ovarian cancer is the 9th most common cancer in women and although it only accounts for approximatel...

View Blog �
Are you receiving the Valley Health News Service?

Sign Up Today

Copyright ©  Valley Health System. All rights reserved.

Nondiscrimination Notice – English Español 한국어 繁體中文 हिंदी Tiếng Việt Kreyòl Français ગુજરાતી Italiano Polski Português Русский Tagalog اُردُو العربية